Dengue is a greater threat to Europe than to the US, and getting orphan drug status means that clearing clinical trials in one sovereignty applies to the entire EMA. Orphan drug status in the US also means that EMA testing can be included in the INDA submission packet for advanced trial start here.
News 
Market Data 
Discover 
AI
